Last 12 months
Inside the activity.
1 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 02, 2025 Filed Dec 5, 2025 00:32 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock, $0.01 Par Value | 107,920 | $4.55 | $491,036.00 |
DisclosureSEC source: 0001193125-25-308350 · ownership.xml · nonDerivative · entry 1 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,612,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2025 Filed Dec 5, 2025 00:27 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 87,780 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001193125-25-308347 · ownership.xml · derivative · entry 7 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.01 Par Value · 87,780 shares Expires 2026-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2025 Filed Dec 5, 2025 00:27 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001193125-25-308347 · ownership.xml · derivative · entry 6 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.01 Par Value · 20,000 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2025 Filed Dec 5, 2025 00:27 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001193125-25-308347 · ownership.xml · derivative · entry 5 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.01 Par Value · 20,000 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2025 Filed Dec 5, 2025 00:27 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001193125-25-308347 · ownership.xml · derivative · entry 4 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.01 Par Value · 20,000 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2025 Filed Dec 5, 2025 00:27 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
SaleCommon Stock, $0.01 Par Value | 147,780 | $5.57 | $823,134.60 |
DisclosureSEC source: 0001193125-25-308347 · ownership.xml · nonDerivative · entry 3 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 841,719 F1 · kind: Transaction occurred pursuant to Rule 10b5-1 Plan established August 27, 2025. F2 · price: The weighted average sales price of the reported transaction was $5.57 based on a range of prices between $5.50 and $5.63. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| December 02, 2025 Filed Dec 5, 2025 00:27 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
Exercise / conversionCommon Stock, $0.01 Par Value | 87,780 | $4.60 | $403,788.00 |
DisclosureSEC source: 0001193125-25-308347 · ownership.xml · nonDerivative · entry 2 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 989,499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2025 Filed Dec 5, 2025 00:27 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
Exercise / conversionCommon Stock, $0.01 Par Value | 60,000 | $4.55 | $273,000.00 |
DisclosureSEC source: 0001193125-25-308347 · ownership.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 901,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2025 Filed Nov 15, 2025 01:00 UTC |
Singh Sanjay REVP Technical Operations
|
SaleCommon Stock, $0.01 Par Value | 18,777 | $5.03 | $94,448.31 |
DisclosureSEC source: 0001193125-25-283569 · ownership.xml · nonDerivative · entry 1 Singh Sanjay R · CIK 0001953423 · EVP Technical Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 455,211 F1 · kind: Transaction occured pursuant to Rule 10B5-1 Plan established May 14, 2025. F2 · price: The weighted average sales price of the reported transaction was $5.03 based on a range of prices between $5.00 and $5.07. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 01:00 UTC |
Ahuja AjayChief Medical Officer
|
GrantCommon Stock, $0.01 Par Value | 318,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-278295 · ownership.xml · nonDerivative · entry 1 Ahuja Ajay · CIK 0002090878 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,200 F1 · kind: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · kind: Four-year vesting schedule with no shares vesting on the first anniversary of the vesting determination date of September 29, 2025 and one-third on each anniversary thereafter until fully vested on the fourth anniversary of the vesting determination date. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 01:16 UTC |
Singh Sanjay REVP Technical Operations
|
Tax withholdingCommon Stock, $0.01 Par Value | 17,071 | $5.59 | $95,426.89 |
DisclosureSEC source: 0001193125-25-263121 · ownership.xml · nonDerivative · entry 1 Singh Sanjay R · CIK 0001953423 · EVP Technical Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 473,988 F1 · kind: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of previously reported restricted stock units. Read SEC document |
| September 16, 2025 Filed Sep 17, 2025 23:39 UTC |
Tross Stuart AChief People & Workpl Officer
|
SaleCommon Stock, $0.01 Par Value | 47,000 | $5.34 | $250,980.00 |
DisclosureSEC source: 0001193125-25-206517 · ownership.xml · nonDerivative · entry 1 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,032,013 F1 · kind: Transaction occured pursuant to Rule 10B5-1 Plan established June 17, 2025. F2 · price: The weighted average sales price of the reported transaction was $5.34 based on a range of prices between $5.33 and $5.39. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 05, 2025 Filed Aug 7, 2025 00:00 UTC |
Tross Stuart AChief People & Workpl Officer
|
GrantCommon Stock, $0.01 Par Value | 12,755 | $3.92 | $49,999.60 |
DisclosureSEC source: 0000950170-25-104395 · ownership.xml · nonDerivative · entry 1 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,079,013 F1 · kind: The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective May 13, 2023. The purchase was approved by the Company's Board of Directors on August 5, 2025. Read SEC document |
| July 16, 2025 Filed Jul 18, 2025 00:51 UTC |
Binder Steven B.Director
|
SaleCommon Stock, $0.01 Par Value | 75,367 | $3.94 | $296,945.98 |
DisclosureSEC source: 0000950170-25-096744 · ownership.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 830,508 F2 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan established August 16, 2024. F3 · price: The weighted average sales price of the reported transaction was $3.94 based on a range of prices between $3.91 and $3.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 16, 2025 Filed Jul 18, 2025 00:46 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
SaleCommon Stock, $0.01 Par Value | 7,466 | $3.94 | $29,416.04 |
DisclosureSEC source: 0000950170-25-096737 · ownership.xml · nonDerivative · entry 2 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 841,719 F2 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan established August 19, 2024. F3 · price: The weighted average sales price of the reported transaction was $3.94 based on a range of prices between $3.90 and $3.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 15, 2025 Filed Jul 18, 2025 00:51 UTC |
Binder Steven B.Director
|
Tax withholdingCommon Stock, $0.01 Par Value | 19,383 | $3.85 | $74,624.55 |
DisclosureSEC source: 0000950170-25-096744 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 905,875 F1 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| July 15, 2025 Filed Jul 18, 2025 00:48 UTC |
BLANK BURKHARDEVP Chief Medical Officer
|
Tax withholdingCommon Stock, $0.01 Par Value | 9,556 | $3.85 | $36,790.60 |
DisclosureSEC source: 0000950170-25-096742 · ownership.xml · nonDerivative · entry 1 BLANK BURKHARD · CIK 0001073409 · EVP Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 460,791 F1 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. F2 · balance_after: Includes 1,335 shares and 3,888 shares acquired under the Issuer's Employee Stock Purchase Plan on December 31, 2024 and June 30, 2025, respectively. Read SEC document |
| July 15, 2025 Filed Jul 18, 2025 00:48 UTC |
Singh Sanjay REVP Technical Operations
|
Tax withholdingCommon Stock, $0.01 Par Value | 15,450 | $3.85 | $59,482.50 |
DisclosureSEC source: 0000950170-25-096741 · ownership.xml · nonDerivative · entry 1 Singh Sanjay R · CIK 0001953423 · EVP Technical Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 491,059 F1 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| July 15, 2025 Filed Jul 18, 2025 00:47 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
Tax withholdingCommon Stock, $0.01 Par Value | 111,275 | $3.85 | $428,408.75 |
DisclosureSEC source: 0000950170-25-096740 · ownership.xml · nonDerivative · entry 1 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,504,792 F1 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. F2 · balance_after: Includes 3,133 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025. Read SEC document |
| July 15, 2025 Filed Jul 18, 2025 00:46 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
Tax withholdingCommon Stock, $0.01 Par Value | 30,361 | $3.85 | $116,889.85 |
DisclosureSEC source: 0000950170-25-096737 · ownership.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 849,185 F1 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| July 15, 2025 Filed Jul 18, 2025 00:46 UTC |
Tross Stuart AChief People & Workpl Officer
|
Tax withholdingCommon Stock, $0.01 Par Value | 28,057 | $3.85 | $108,019.45 |
DisclosureSEC source: 0000950170-25-096738 · ownership.xml · nonDerivative · entry 1 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,066,258 F1 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. F2 · balance_after: Includes 3,888 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025. Read SEC document |
| July 15, 2025 Filed Jul 18, 2025 00:45 UTC |
Sabella Lauren MEVP Operations
|
Tax withholdingCommon Stock, $0.01 Par Value | 11,896 | $3.85 | $45,799.60 |
DisclosureSEC source: 0000950170-25-096736 · ownership.xml · nonDerivative · entry 1 Sabella Lauren M · CIK 0001360928 · EVP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,841 F1 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. F2 · balance_after: Includes 3,888 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025. Read SEC document |
| July 15, 2025 Filed Jul 18, 2025 00:45 UTC |
Prentiss Christopher BChief Financial Officer
|
Tax withholdingCommon Stock, $0.01 Par Value | 11,540 | $3.85 | $44,429.00 |
DisclosureSEC source: 0000950170-25-096735 · ownership.xml · nonDerivative · entry 1 Prentiss Christopher B · CIK 0001717583 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 343,854 F1 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. F2 · balance_after: Includes 2,201 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025. Read SEC document |
| June 23, 2025 Filed Jun 26, 2025 01:00 UTC |
Marasco DominicPres, Endocrine Business Unit
|
GrantPerformance Restricted Stock Unit · Derivative | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-090116 · ownership.xml · derivative · entry 1 Marasco Dominic · CIK 0002053897 · Pres, Endocrine Business Unit 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock, $0.01 Par Value · 1,000,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: The performance-based restricted stock unit will vest on March 15, 2028. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, will be determined by the achievement of a specified net sales target, with the potential payout ranging from 0% to 200%. F2 · derivative.expiration_date: The performance-based restricted stock unit will vest on March 15, 2028. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, will be determined by the achievement of a specified net sales target, with the potential payout ranging from 0% to 200%. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 00:07 UTC |
Binder Steven B.Director
|
SaleCommon Stock, $0.01 Par Value | 64,085 | $4.00 | $256,340.00 |
DisclosureSEC source: 0000950170-25-084587 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 925,258 F1 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan established August 19, 2024. F2 · price: The weighted average sales price of the reported transaction was $4.00 based on a range of prices between $3.91 and $4.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| May 27, 2025 Filed May 27, 2025 23:26 UTC |
BLANK BURKHARDEVP Chief Medical Officer
|
Tax withholdingCommon Stock, $0.01 Par Value | 15,630 | $4.12 | $64,395.60 |
DisclosureSEC source: 0000950170-25-077997 · ownership.xml · nonDerivative · entry 1 BLANK BURKHARD · CIK 0001073409 · EVP Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 465,124 F1 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 20, 2025 Filed May 21, 2025 01:45 UTC |
Binder Steven B.Director
|
SaleCommon Stock, $0.01 Par Value | 12,078 | $4.40 | $53,143.20 |
DisclosureSEC source: 0000950170-25-075536 · ownership.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 989,343 F2 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan established August 19, 2024. F3 · price: The weighted average sales price of the reported transaction was $4.40 based on a range of prices between $4.37 and $4.46. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| May 20, 2025 Filed May 21, 2025 01:44 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
SaleCommon Stock, $0.01 Par Value | 2,345 | $4.41 | $10,341.45 |
DisclosureSEC source: 0000950170-25-075534 · ownership.xml · nonDerivative · entry 2 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 879,546 F2 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan established August 19, 2024. F3 · price: The weighted average sales price of the reported transaction was $4.41 based on a range of prices between $4.38 and $4.46. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| May 19, 2025 Filed May 21, 2025 01:47 UTC |
Tross Stuart AChief People & Workpl Officer
|
Tax withholdingCommon Stock, $0.01 Par Value | 6,147 | $4.37 | $26,862.39 |
DisclosureSEC source: 0000950170-25-075540 · ownership.xml · nonDerivative · entry 1 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,090,427 F1 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 19, 2025 Filed May 21, 2025 01:46 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
Tax withholdingCommon Stock, $0.01 Par Value | 26,114 | $4.37 | $114,118.18 |
DisclosureSEC source: 0000950170-25-075538 · ownership.xml · nonDerivative · entry 1 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,612,934 F1 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 19, 2025 Filed May 21, 2025 01:45 UTC |
Binder Steven B.Director
|
Tax withholdingCommon Stock, $0.01 Par Value | 5,190 | $4.37 | $22,680.30 |
DisclosureSEC source: 0000950170-25-075536 · ownership.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,001,421 F1 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 19, 2025 Filed May 21, 2025 01:44 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
Tax withholdingCommon Stock, $0.01 Par Value | 9,536 | $4.37 | $41,672.32 |
DisclosureSEC source: 0000950170-25-075534 · ownership.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 881,891 F1 · kind: Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 14, 2025 Filed May 16, 2025 01:35 UTC |
Binder Steven B.Director
|
GrantRestricted Stock Unit · Derivative | 52,854 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073081 · ownership.xml · derivative · entry 5 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,854 Underlying: Common Stock, $0.01 Par Value · 52,854 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F6 · kind: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F6 · derivative.exercise_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F6 · derivative.expiration_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. Read SEC document |
| May 14, 2025 Filed May 16, 2025 22:20 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
GrantCommon Stock, $0.01 Par Value | 27,000 | $4.56 | $123,120.00 |
DisclosureSEC source: 0000950170-25-073801 · ownership.xml · nonDerivative · entry 1 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,639,048 F1 · kind: The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective May 13, 2023. The purchase was approved by the Company's Board of Directors on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 16, 2025 22:20 UTC |
Marasco DominicPres, Endocrine Business Unit
|
GrantPerformance Restricted Stock Unit · Derivative | 72,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073800 · ownership.xml · derivative · entry 3 Marasco Dominic · CIK 0002053897 · Pres, Endocrine Business Unit 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,500 Underlying: Common Stock, $0.01 Par Value · 72,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F4 · derivative.exercise_date: The performance-based restricted stock unit will vest on July 15, 2028. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from July 1, 2025 until June 30, 2028 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same three-year period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. F4 · derivative.expiration_date: The performance-based restricted stock unit will vest on July 15, 2028. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from July 1, 2025 until June 30, 2028 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same three-year period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| May 14, 2025 Filed May 16, 2025 22:20 UTC |
Marasco DominicPres, Endocrine Business Unit
|
GrantCommon Stock, $0.01 Par Value | 21,929 | $4.56 | $99,996.24 |
DisclosureSEC source: 0000950170-25-073800 · ownership.xml · nonDerivative · entry 2 Marasco Dominic · CIK 0002053897 · Pres, Endocrine Business Unit 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,429 F2 · kind: The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective May 13, 2023. The purchase was approved by the Company's Board of Directors on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 16, 2025 22:20 UTC |
Marasco DominicPres, Endocrine Business Unit
|
GrantCommon Stock, $0.01 Par Value | 59,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073800 · ownership.xml · nonDerivative · entry 1 Marasco Dominic · CIK 0002053897 · Pres, Endocrine Business Unit 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 311,500 F1 · kind: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on July 15, 2026 and each yearly anniversary thereof until fully vested. Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. Read SEC document |
| May 14, 2025 Filed May 16, 2025 22:10 UTC |
HOOPER ANTHONY CDirector
|
GrantRestricted Stock Unit · Derivative | 10,571 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073790 · ownership.xml · derivative · entry 3 HOOPER ANTHONY C · CIK 0001277244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,571 Underlying: Common Stock, $0.01 Par Value · 10,571 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F4 · derivative.exercise_date: Award granted in lieu of annual cash retainer payment for non-employee directors. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F4 · derivative.expiration_date: Award granted in lieu of annual cash retainer payment for non-employee directors. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service from the board of directors of MannKind Corporation. Read SEC document |
| May 14, 2025 Filed May 16, 2025 22:10 UTC |
HOOPER ANTHONY CDirector
|
GrantRestricted Stock Unit · Derivative | 52,854 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073790 · ownership.xml · derivative · entry 2 HOOPER ANTHONY C · CIK 0001277244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,854 Underlying: Common Stock, $0.01 Par Value · 52,854 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F3 · kind: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F3 · derivative.exercise_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F3 · derivative.expiration_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. Read SEC document |
| May 14, 2025 Filed May 16, 2025 22:10 UTC |
HOOPER ANTHONY CDirector
|
GrantCommon Stock, $0.01 Par Value | 25,000 | $4.56 | $114,000.00 |
DisclosureSEC source: 0000950170-25-073790 · ownership.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,153 F1 · kind: The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective May 13, 2023. The purchase was approved by the Company's Board of Directors on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 16, 2025 22:09 UTC |
Shannon James SamuelDirector
|
GrantRestricted Stock Unit · Derivative | 52,854 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073786 · ownership.xml · derivative · entry 1 Shannon James Samuel · CIK 0001485417 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,854 Underlying: Common Stock, $0.01 Par Value · 52,854 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · kind: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F2 · derivative.exercise_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F2 · derivative.expiration_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. Read SEC document |
| May 14, 2025 Filed May 16, 2025 22:08 UTC |
Grancio JenniferDirector
|
GrantRestricted Stock Unit · Derivative | 52,854 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073785 · ownership.xml · derivative · entry 1 Grancio Jennifer · CIK 0001807888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,854 Underlying: Common Stock, $0.01 Par Value · 52,854 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · kind: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F2 · derivative.exercise_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F2 · derivative.expiration_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. Read SEC document |
| May 14, 2025 Filed May 16, 2025 22:08 UTC |
MUNDKUR CHRISTINEDirector
|
GrantRestricted Stock Unit · Derivative | 52,854 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073782 · ownership.xml · derivative · entry 1 MUNDKUR CHRISTINE · CIK 0001237264 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,854 Underlying: Common Stock, $0.01 Par Value · 52,854 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · kind: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F2 · derivative.exercise_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F2 · derivative.expiration_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. Read SEC document |
| May 14, 2025 Filed May 16, 2025 22:07 UTC |
Friedman Michael ADirector
|
GrantRestricted Stock Unit · Derivative | 52,854 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073777 · ownership.xml · derivative · entry 1 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,854 Underlying: Common Stock, $0.01 Par Value · 52,854 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · kind: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F2 · derivative.exercise_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F2 · derivative.expiration_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. Read SEC document |
| May 14, 2025 Filed May 16, 2025 22:06 UTC |
Consiglio Ronald JDirector
|
GrantRestricted Stock Unit · Derivative | 52,854 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073775 · ownership.xml · derivative · entry 1 CONSIGLIO RONALD J · CIK 0001232088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,854 Underlying: Common Stock, $0.01 Par Value · 52,854 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · kind: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F2 · derivative.exercise_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F2 · derivative.expiration_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. Read SEC document |
| May 14, 2025 Filed May 16, 2025 22:05 UTC |
Kay SabrinaDirector
|
GrantRestricted Stock Unit · Derivative | 10,571 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073769 · ownership.xml · derivative · entry 2 Kay Sabrina · CIK 0001835895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,571 Underlying: Common Stock, $0.01 Par Value · 10,571 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F3 · derivative.exercise_date: Award granted in lieu of annual cash retainer payment for non-employee directors. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F3 · derivative.expiration_date: Award granted in lieu of annual cash retainer payment for non-employee directors. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service from the board of directors of MannKind Corporation. Read SEC document |
| May 14, 2025 Filed May 16, 2025 22:05 UTC |
Kay SabrinaDirector
|
GrantRestricted Stock Unit · Derivative | 52,854 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073769 · ownership.xml · derivative · entry 1 Kay Sabrina · CIK 0001835895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,854 Underlying: Common Stock, $0.01 Par Value · 52,854 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · kind: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F2 · derivative.exercise_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. F2 · derivative.expiration_date: Restricted stock unit vested on May 14, 2025, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. Read SEC document |
| May 13, 2025 Filed May 16, 2025 01:35 UTC |
Binder Steven B.Director
|
SaleCommon Stock, $0.01 Par Value | 80,144 | $4.69 | $375,875.36 |
DisclosureSEC source: 0000950170-25-073081 · ownership.xml · nonDerivative · entry 4 Binder Steven B. · CIK 0001712601 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,006,611 F3 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan established August 16, 2024. F4 · price: The weighted average sales price of the reported transaction was $4.69 based on a range of prices between $4.65 and $4.81. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| May 13, 2025 Filed May 16, 2025 01:37 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
GrantPerformance Restricted Stock Unit · Derivative | 145,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073082 · ownership.xml · derivative · entry 6 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,000 Underlying: Common Stock, $0.01 Par Value · 145,000 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F7 · derivative.exercise_date: The performance-based restricted stock unit will vest on July 15, 2028. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from July 1, 2025 until June 30, 2028 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same three-year period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. F7 · derivative.expiration_date: The performance-based restricted stock unit will vest on July 15, 2028. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from July 1, 2025 until June 30, 2028 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same three-year period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| May 13, 2025 Filed May 16, 2025 01:37 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
GrantCommon Stock, $0.01 Par Value | 119,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-073082 · ownership.xml · nonDerivative · entry 5 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 891,427 F5 · kind: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on July 15, 2026 and each yearly anniversary thereof until fully vested. Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.